Danske Bank A S lifted its stake in Albemarle Corporation (NYSE:ALB – Free Report) by 56,770.5% during the third quarter, Holdings Channel reports. The fund owned 227,482 shares of the specialty chemicals company’s stock after acquiring an additional 227,082 shares during the quarter. Danske Bank A S’s holdings in Albemarle were worth $24,063,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ALB. Ethic Inc. lifted its stake in shares of Albemarle by 233.0% in the third quarter. Ethic Inc. now owns 71,694 shares of the specialty chemicals company’s stock worth $7,584,000 after buying an additional 50,167 shares during the last quarter. AEGON ASSET MANAGEMENT UK Plc grew its stake in Albemarle by 5,070.9% in the 3rd quarter. AEGON ASSET MANAGEMENT UK Plc now owns 85,579 shares of the specialty chemicals company’s stock valued at $9,053,000 after buying an additional 83,924 shares during the last quarter. Wellington Management Group LLP grew its stake in Albemarle by 161.8% in the 2nd quarter. Wellington Management Group LLP now owns 49,412 shares of the specialty chemicals company’s stock valued at $6,672,000 after buying an additional 30,541 shares during the last quarter. Great Lakes Advisors LLC acquired a new position in Albemarle in the 2nd quarter valued at $4,246,000. Finally, WINTON GROUP Ltd bought a new position in Albemarle in the 2nd quarter worth $4,145,000. 92.87% of the stock is currently owned by institutional investors and hedge funds.
Albemarle Stock Down 5.9%
Shares of ALB opened at $88.03 on Tuesday. The stock has a market cap of $10.39 billion, a price-to-earnings ratio of 21.26, a P/E/G ratio of 0.59 and a beta of 1.34. The company has a quick ratio of 1.57, a current ratio of 2.34 and a debt-to-equity ratio of 0.21. Albemarle Corporation has a 12 month low of $87.78 and a 12 month high of $221.00. The company has a 50-day moving average price of $102.84 and a two-hundred day moving average price of $145.08.
Albemarle (NYSE:ALB – Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The specialty chemicals company reported $2.58 earnings per share for the quarter, beating analysts’ consensus estimates of $2.53 by $0.05. Albemarle had a return on equity of 14.91% and a net margin of 10.40%. The company had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.52 billion. During the same period in the previous year, the business earned ($0.19) earnings per share. The company’s quarterly revenue was up 18.8% on a year-over-year basis. Equities analysts predict that Albemarle Corporation will post 10.64 EPS for the current fiscal year.
Albemarle Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Friday, December 18th will be given a dividend of $0.41 per share. This represents a $1.64 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Friday, December 18th. Albemarle’s dividend payout ratio (DPR) is 39.61%.
Analyst Upgrades and Downgrades
Several equities research analysts have recently issued reports on the company. HSBC lowered their price target on Albemarle from $230.00 to $170.00 and set a “buy” rating on the stock in a research report on Thursday, July 23rd. UBS Group cut their price objective on Albemarle from $150.00 to $137.00 and set a “buy” rating for the company in a research report on Monday, November 9th. Citigroup boosted their price objective on Albemarle from $125.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, November 9th. Rothschild & Co Redburn decreased their target price on Albemarle from $100.00 to $86.00 in a research note on Wednesday, November 11th. Finally, Robert W. Baird lowered their target price on Albemarle from $157.00 to $123.00 in a report on Wednesday, October 14th. Fifteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $152.63.
Get Our Latest Research Report on Albemarle
Albemarle Profile
Albemarle Corporation is a specialty chemicals company that produces lithium, bromine and refining catalysts. Its products serve industries including energy storage, transportation, electronics, petroleum refining and pharmaceuticals. The company supplies lithium compounds used in rechargeable batteries and other applications. It also makes bromine-based products for uses such as flame retardants and water treatment, along with catalysts used in refining petroleum. Albemarle traces its history to 1887 and is headquartered in Charlotte, North Carolina.
See Also
- Five stocks we like better than Albemarle
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Corporation (NYSE:ALB – Free Report).
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.
